BACKGROUND: Altus Biologics Inc., based in Cambridge, Massachusetts, is developing and commercializing a new class of high-performance industrial catalysts based on a novel and proprietary technology for stabilizing enzymes. The company's initial products, CLEC or Cross-Linked Enzyme Crystals, are designed to solve critical process chemistry and protein stability issues for a broad array of industrial applications including the manufacture of pharmaceuticals, fine and specialty chemicals, the destruction of chemical warfare agents and as a key component of commercial detergent products. Since 1994, Altus has introduced ten products to the marketplace.

PLATFORMS: Altus runs iSALES on a Mac Power PC server running Mac OS 7.6.1., which is accessed by client users on Mac 6100, 7200 and G3 clients and by remote (PPC) users on Mac duodock 2300c laptops.

Register or login for access to this item and much more

All Information Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access